簡介

本頁面提供了有關 Carlos Alban 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Carlos Alban已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
Director 8,947
US:SWTX / SpringWorks Therapeutics, Inc. Director 0
US:ABBV / AbbVie Inc. Vice Chairman 0
US:ABT / Abbott Laboratories Senior Vice President 95,696
如何解讀這些圖表

以下圖表顯示了在Carlos Alban進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Carlos Alban 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-05-01 2026-04-30 4 SOLV Solventum Corp
Common Stock
M - Exercise 3,403 8,947 61.38
2026-03-30 2026-03-27 4 SOLV Solventum Corp
Common Stock
M - Exercise 1,980 5,544 55.56
2025-07-02 2025-07-01 4 SWTX SpringWorks Therapeutics, Inc.
Common Stock
D - Sale to Issuer -28,861 0 -100.00
2025-05-15 2025-05-13 4 SOLV Solventum Corp
Common Stock
M - Exercise 3,564 3,564
2025-05-15 2025-05-14 4 SWTX SpringWorks Therapeutics, Inc.
Common Stock
A - Award 10,060 28,861 53.51
2024-05-17 2024-05-16 4 SWTX SpringWorks Therapeutics, Inc.
Common Stock
A - Award 4,095 18,801 27.85
2023-05-25 2023-05-24 4 SWTX SpringWorks Therapeutics, Inc.
Common Stock
A - Award 4,648 14,706 46.21
2022-07-15 2022-07-14 4 SWTX SpringWorks Therapeutics, Inc.
Common Stock
A - Award 10,058 10,058
2020-11-18 2020-11-16 4 ABBV AbbVie Inc.
Option(Right to buy)
M - Exercise -115,830 0 -100.00
2020-11-18 2020-11-16 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
S - Sale -115,830 114,899 -50.20 100.00 -11,583,000 11,489,900
2020-11-18 2020-11-16 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
M - Exercise 115,830 230,729 100.81 35.88 4,155,980 8,278,557
2020-07-08 2020-07-07 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
S - Sale -23,000 114,899 -16.68 100.00 -2,300,000 11,489,900
2020-07-08 2020-07-07 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
S - Sale -30,325 137,899 -18.03 100.00 -3,032,555 13,790,148
2020-03-03 2020-02-28 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
F - Taxes -32,092 168,224 -16.02 85.42 -2,741,299 14,369,694
2020-02-24 2020-02-20 4 ABBV AbbVie Inc.
Option (right to buy)
A - Award 114,566 114,566
2020-02-24 2020-02-20 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 10,125 200,316 5.32
2020-02-24 2020-02-20 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 8,214 190,191 4.51
2020-02-24 2020-02-20 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 14,340 181,977 8.55
2020-02-24 2020-02-20 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 39,760 167,637 31.09
2019-03-04 2019-02-28 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
F - Taxes -24,125 127,877 -15.87 79.41 -1,915,766 10,154,713
2019-02-22 2019-02-21 4 ABBV AbbVie Inc.
Option (right to buy)
A - Award 62,305 62,305
2019-02-22 2019-02-21 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 8,215 152,002 5.71
2019-02-22 2019-02-21 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 14,340 143,787 11.08
2019-02-22 2019-02-21 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 13,350 129,447 11.50
2019-02-22 2019-02-21 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 18,545 116,097 19.01
2018-03-02 2018-03-01 4 ABBV AbbVie Inc.
Option (right to buy)
M - Exercise -48,100 0 -100.00
2018-03-02 2018-03-01 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
S - Sale -14,829 97,552 -13.20 114.43 -1,696,850 11,162,661
2018-03-02 2018-03-01 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
S - Sale -46,997 112,381 -29.49 114.63 -5,387,463 12,882,706
2018-03-02 2018-03-01 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
S - Sale -19,169 159,378 -10.74 113.75 -2,180,495 18,129,423
2018-03-02 2018-03-01 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
M - Exercise 48,100 178,547 36.87 29.23 1,405,795 5,218,304
2018-03-02 2018-02-28 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
S - Sale -2,579 130,447 -1.94 117.85 -303,928 15,372,840
2018-03-02 2018-02-28 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
F - Taxes -25,976 133,026 -16.34 118.26 -3,071,922 15,731,655
2018-02-16 2018-02-15 4 ABBV AbbVie Inc.
Option (right to buy)
A - Award 44,430 44,430
2018-02-16 2018-02-15 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 14,340 159,002 9.91
2018-02-16 2018-02-15 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 16,567 144,662 12.93
2018-02-16 2018-02-15 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 13,350 128,950 11.55
2017-06-15 2017-06-14 4 ABBV AbbVie Inc.
Option (right to buy)
M - Exercise -45,800 0 -100.00
2017-06-15 2017-06-14 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
S - Sale -45,800 114,745 -28.53 70.00 -3,206,000 8,032,150
2017-06-15 2017-06-14 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
M - Exercise 45,800 160,545 39.91 24.21 1,108,736 3,886,505
2017-05-08 2017-05-04 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
S - Sale -43,000 114,745 -27.26 67.00 -2,881,000 7,687,915
2017-03-02 2017-02-28 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
F - Taxes -34,721 157,745 -18.04 62.22 -2,160,341 9,814,894
2017-02-21 2017-02-16 4 ABBV AbbVie Inc.
Option (right to buy)
A - Award 95,750 95,750
2017-02-21 2017-02-16 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 13,350 192,466 7.45
2017-02-21 2017-02-16 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 29,672 179,116 19.85
2016-05-12 2016-05-10 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
S - Sale -47,438 149,444 -24.09 63.52 -3,013,262 9,492,683
2016-03-02 2016-02-29 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
F - Taxes -39,930 196,882 -16.86 56.00 -2,236,080 11,025,392
2016-02-22 2016-02-18 4 ABBV AbbVie Inc.
Option (right to buy)
A - Award 79,870 79,870
2015-03-03 2015-02-28 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
F - Taxes -7,200 236,812 -2.95 60.50 -435,600 14,327,126
2015-03-03 2015-02-27 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
F - Taxes -12,706 244,012 -4.95 60.52 -768,967 14,767,606
2015-02-23 2015-02-19 4 ABBV AbbVie Inc.
Option (right to buy)
A - Award 101,960 101,960
2015-02-23 2015-02-19 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 51,580 256,718 25.14
2014-03-04 2014-03-03 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
S - Sale -600 205,138 -0.29 50.09 -30,056 10,276,183
2014-03-04 2014-03-03 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
S - Sale -400 205,738 -0.19 50.09 -20,036 10,305,622
2014-03-04 2014-03-03 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
S - Sale -282 206,138 -0.14 50.09 -14,125 10,325,452
2014-03-04 2014-03-03 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
S - Sale -1,600 206,420 -0.77 50.09 -80,138 10,338,752
2014-03-04 2014-02-28 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
F - Taxes -15,319 208,020 -6.86 50.91 -779,890 10,590,298
2014-02-24 2014-02-20 4 ABBV AbbVie Inc.
Option (right to buy)
A - Award 81,500 81,500
2014-02-24 2014-02-20 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 47,260 223,339 26.84
2013-05-03 2013-05-01 4 ABBV AbbVie Inc.
Option (right to buy)
M - Exercise -34,600 0 -100.00
2013-05-03 2013-05-01 4 ABBV AbbVie Inc.
Option (right to buy)
M - Exercise -21,000 0 -100.00
2013-05-03 2013-05-01 4 ABBV AbbVie Inc.
Option (right to buy)
M - Exercise -17,700 0 -100.00
2013-05-03 2013-05-01 4 ABBV AbbVie Inc.
Option (right to buy)
M - Exercise -33,900 0 -100.00
2013-05-03 2013-05-01 4 ABBV AbbVie Inc.
Option (right to buy)
M - Exercise -35,700 0 -100.00
2013-05-03 2013-05-01 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
S - Sale -27,664 176,079 -13.58 45.68 -1,263,683 8,043,236
2013-05-03 2013-05-01 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
S - Sale -30,550 203,743 -13.04 45.68 -1,395,426 9,306,328
2013-05-03 2013-05-01 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
S - Sale -27,320 234,293 -10.44 45.66 -1,247,562 10,698,943
2013-05-03 2013-05-01 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
S - Sale -28,122 261,613 -9.71 45.68 -1,284,717 11,951,450
2013-05-03 2013-05-01 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
M - Exercise 34,600 289,735 13.56 28.31 979,602 8,203,035
2013-05-03 2013-05-01 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
M - Exercise 21,000 255,135 8.97 26.85 563,791 6,849,660
2013-05-03 2013-05-01 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
M - Exercise 17,700 234,135 8.18 28.13 497,814 6,585,070
2013-05-03 2013-05-01 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
M - Exercise 33,900 216,435 18.57 28.86 978,449 6,246,920
2013-05-03 2013-05-01 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
M - Exercise 35,700 182,535 24.31 27.29 974,396 4,982,110
2013-03-04 2013-02-28 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
F - Taxes -12,960 146,835 -8.11 36.73 -476,021 5,393,250
2013-02-19 2013-02-19 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
F - Taxes -9,826 159,795 -5.79 37.58 -369,261 6,005,096
2013-02-19 2013-02-14 4 ABBV AbbVie Inc.
Option (right to buy)
A - Award 115,830 115,830
2013-02-19 2013-02-14 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 56,700 169,621 50.21
2013-02-07 2013-02-05 4 ABBV AbbVie Inc.
Option (right to buy)
M - Exercise -2,482 0 -100.00
2013-02-07 2013-02-05 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
F - Taxes -2,325 112,921 -2.02 37.28 -86,676 4,209,695
2013-02-07 2013-02-05 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
M - Exercise 2,482 115,246 2.20 33.80 83,887 3,895,084
2012-12-07 3 ABBV AbbVie Inc.
Common stock, $0.01 par value
0
2012-12-04 2012-12-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 18,453 95,696 23.89
2012-12-04 2012-11-16 4 ABT ABBOTT LABORATORIES
Common shares without par value
G - Gift 40,442 40,442
2012-12-04 2012-11-16 4 ABT ABBOTT LABORATORIES
Common shares without par value
G - Gift -40,442 77,243 -34.36
2012-10-17 2012-10-15 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -2,032 117,685 -1.70 69.28 -140,777 8,153,217
2012-10-17 2012-10-15 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 4,900 119,717 4.27
2012-09-27 2012-09-25 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -1,198 0 -100.00
2012-09-27 2012-09-25 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,198 114,817 -1.03 70.00 -83,860 8,037,190
2012-09-27 2012-09-25 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 1,198 116,015 1.04 57.25 68,586 6,641,859
2012-09-21 2012-09-20 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -1,918 0 -100.00
2012-09-21 2012-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,918 114,817 -1.64 69.75 -133,780 8,008,486
2012-09-21 2012-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 1,918 116,735 1.67 56.98 109,288 6,651,560
2012-09-17 2012-09-13 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -1,331
2012-09-17 2012-09-13 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,331 114,817 -1.15 68.75 -91,506 7,893,669
2012-09-17 2012-09-13 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 1,331 116,148 1.16 56.00 74,536 6,504,288
2012-08-01 2012-07-30 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -352 114,817 -0.31 66.62 -23,451 7,649,453
2012-07-30 2012-07-27 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -1,538 0 -100.00
2012-07-30 2012-07-27 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -30,800 0 -100.00
2012-07-30 2012-07-27 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -5,200 0 -100.00
2012-07-30 2012-07-27 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -7,299 0 -100.00
2012-07-30 2012-07-27 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,538 115,169 -1.32 66.00 -101,508 7,601,154
2012-07-30 2012-07-27 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -43,299 116,707 -27.06 65.00 -2,814,435 7,585,955
2012-07-30 2012-07-27 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 1,538 160,006 0.97 56.98 87,635 9,117,142
2012-07-30 2012-07-27 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 30,800 158,468 24.13 41.48 1,277,584 6,573,253
2012-07-30 2012-07-27 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 5,200 127,668 4.25 44.16 229,632 5,637,819
2012-07-30 2012-07-27 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 7,299 122,468 6.34 46.34 338,236 5,675,167
2012-07-25 2012-07-23 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 2,482 2,482
2012-07-25 2012-07-23 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -2,834 0 -100.00
2012-07-25 2012-07-23 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -2,601 0 -100.00
2012-07-25 2012-07-23 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -4,334 115,169 -3.63 65.06 -281,970 7,492,895
2012-07-25 2012-07-23 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 2,834 119,503 2.43 51.28 145,328 6,128,114
2012-07-25 2012-07-23 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 2,601 116,669 2.28 46.34 120,530 5,406,441
2012-03-22 2012-03-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -140 0 -100.00 60.22 -8,431
2012-03-22 2012-03-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -684 0 -100.00 60.22 -41,191
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,204 114,068 -1.04 56.71 -68,282 6,469,138
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -8,868 115,272 -7.14 57.04 -505,831 6,575,115
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 4,166 124,140 3.47
2012-02-22 2012-02-17 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 48,100 48,100
2012-02-22 2012-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 26,700 119,974 28.63
2009-10-19 3 ABT ABBOTT LABORATORIES
Common shares without par value
26,107
2009-10-19 3 ABT ABBOTT LABORATORIES
Common shares without par value
627
2009-10-19 3 ABT ABBOTT LABORATORIES
Common shares without par value
128
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)